These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13778866)

  • 1. The current status of sulphonylureas in experimental and clinical diabetes.
    TYLER DB
    J Indian Med Assoc; 1960 Dec; 35():549-51. PubMed ID: 13778866
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the sulphonylureas on fibrinolysis.
    FEARNLEY GR; CHAKRABARTI R; VINCENT CT
    Lancet; 1960 Sep; 2(7151):622-5. PubMed ID: 13698486
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and hazards of an experimental hypoglycemic sulfonylurea compound: metahexamide].
    VERNET A; RILLIET B
    Praxis; 1960 Jun; 49():620-3. PubMed ID: 13841881
    [No Abstract]   [Full Text] [Related]  

  • 4. PHARMACOLOGY AND MODE OF ACTION OF THE HYPOGLYCAEMIC SULPHONYLUREAS AND DIGUANIDES.
    DUNCAN LJ; CLARKE BF
    Annu Rev Pharmacol; 1965; 5():151-62. PubMed ID: 14287878
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology and mode of action of the sulphonylureas in man.
    STOWERS JM; MAHLER RF; HUNTER RB
    Lancet; 1958 Feb; 1(7015):278-83. PubMed ID: 13515183
    [No Abstract]   [Full Text] [Related]  

  • 7. Disulfiramlike actions produced by hypoglycemic sulfonylurea compounds.
    TRUITT EB; DURITZ G; MORGAN AM; PROUTY RW
    Q J Stud Alcohol; 1962 Jun; 23():197-207. PubMed ID: 13922688
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the problem of the protective effect of sulfonylurea derivatives on the liver].
    KNICK B; RUCKES J
    Verh Dtsch Ges Inn Med; 1959; 65():709-12. PubMed ID: 14410106
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative pharmacology of the sulfonylureas.
    RADDING RS; KERN LR; OWENS JC
    Metabolism; 1962 Apr; 11():411-5. PubMed ID: 14489728
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-term use of sulphonylureas in diabetes mellitus.
    STOWERS JM; BEWSHER PD
    Lancet; 1962 Jan; 1(7221):122-5. PubMed ID: 13917576
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of long-term sulfonylurea treatment on the haematopoietic system of diabetic patients.
    JAKOBSON T
    Ann Med Intern Fenn; 1961; 50():83-93. PubMed ID: 13789246
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of sulfonylurea on proliferating connective tissue in the liver].
    PETZOLD H; STOEHR K
    Verh Dtsch Ges Inn Med; 1959; 65():455-9. PubMed ID: 14432454
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results in treatment of diabetes mellitus with the sulphonylureas.
    GORMAN CK; WEAVER JA
    Br Med J; 1959 Dec; 2(5161):1214-7. PubMed ID: 13851323
    [No Abstract]   [Full Text] [Related]  

  • 14. A new high potency antidiabetic sulfonylurea [N-(1-hexahydro-1-azepinyl)-N'-p-tolyl-sulfonylurea].
    DULIN WE; OSTER HL; McMAHON FG
    Proc Soc Exp Biol Med; 1961 Jun; 107():245-8. PubMed ID: 13724915
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism and relative hypoglycemic potencies of four sulfonylureas in man.
    WEST KM; JOHNSON PC
    Diabetes; 1960; 9():454-8. PubMed ID: 13784586
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function in diabetic patients under long-term sulfonylurea treatment.
    NIKKILA EA; JAKOBSON T; JOKIPII SG; KARLSSON K
    Acta Endocrinol (Copenh); 1960 Apr; 33():623-9. PubMed ID: 14427195
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the significant role of the liver in sulfonylurea hypoglycemia.
    FRAWLEY TF; SHELLEY TF; RUNYAN JW; MARGULIES EJ; CINCOTTI JJ
    Ann N Y Acad Sci; 1959 Sep; 82():460-78. PubMed ID: 13824663
    [No Abstract]   [Full Text] [Related]  

  • 20. Data on the combined action of insulin and hypoglycaemic sulphonylurea.
    TARDOS L; ERDELY I
    Acta Physiol Acad Sci Hung; 1961; 19():297-303. PubMed ID: 13775313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.